- Home
- AOMR vs IVVD Comparison
AOMR vs IVVD Comparison
Compare AOMR & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AOMR | IVVD |
|---|---|---|
| Founded | 2018 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 191.5M | 212.6M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AOMR | IVVD |
|---|---|---|
| Price | $6.17 | $0.60 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | $9.15 | ★ $10.00 |
| AVG Volume (30 Days) | 115.4K | ★ 3.5M |
| Earning Date | 11-03-2026 | 11-24-2026 |
| Dividend Yield | ★ 20.64% | N/A |
| EPS Growth | 53.85 | ★ 79.02 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $53,426,000.00 |
| Revenue This Year | N/A | $12.40 |
| Revenue Next Year | N/A | $44.85 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 110.47 |
| 52 Week Low | $5.94 | $0.53 |
| 52 Week High | $9.30 | $3.07 |
Technical Indicators
Market Signals| Indicator | AOMR | IVVD |
|---|---|---|
| Relative Strength Index (RSI) | 33.70 | 43.64 |
| Support Level | N/A | $0.53 |
| Resistance Level | $9.24 | $1.02 |
| Average True Range (ATR) | 0.29 | 0.05 |
| MACD | -0.07 | 0.01 |
| Stochastic Oscillator | 15.91 | 54.34 |
Price Performance
Historical ComparisonAbout AOMR Angel Oak Mortgage REIT Inc.
Angel Oak Mortgage REIT Inc is a real estate finance company focused on acquiring and investing in first and second lien non-QM loans and other mortgage-related assets in the U.S. mortgage market. Its objective is to generate attractive risk-adjusted returns for its stockholders, through cash distributions and capital appreciation, across interest rate and credit cycles. The company operates in a single operating segment, which is to acquire, invest in, and finance mortgage-related assets.
About IVVD Invivyd Inc.
Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.